This is an Open Access article licensed under the terms of the Creative Commons AttributionNonCommercial 3.0 Unported license (CC BY-NC) (www.karger.com/OA-license), applicable to the online version of the article only. Distribution permitted for non-commercial purposes only. Abstract Aims: Cigarette smoke (CS) in active smokers and second-hand smoke exposure exacerbate respiratory disorders such as asthma and chronic bronchitis. While women are known to experience a more asthmatic response to CS than emphysema in men, there is limited information on the mechanisms of CS-induced airway dysfunction. We hypothesize that CS interferes with a normal (protective) bronchodilatory role of estrogens, thus worsening airway contractility. Methods: We tested effects of cigarette smoke extract (CSE) on 17β-estradiol (E 2 ) signaling in enzymatically-dissociated bronchial airway smooth muscle (ASM) obtained from lung samples of non-smoking female patients undergoing thoracic surgery. Results: In fura-2 loaded ASM cells, CSE increased intracellular calcium ([Ca 2+ ] i ) responses to 10µM histamine. Acute exposure to physiological concentrations of E 2 decreased [Ca 2+ ] i responses. However, in 24h exposed CSE cells, although expression of estrogen receptors was increased, the effect of E 2 on [Ca 2+ ] i was blunted. Acute E 2 exposure also decreased store-operated Ca 2+ entry and inhibited stromal interaction molecule 1 (STIM1) phosphorylation: effects blunted by CSE. Acute exposure to E 2 increased cAMP, but less so in 24h CSE-exposed cells. 24h CSE exposure increased S-nitrosylation of ERα. Furthermore, 24h CSE-exposed bronchial rings showed increased bronchoconstrictor agonist responses that were not reduced as effectively by E 2 compared to non-CSE controls. Conclusion: These data suggest that CS induces dysregulation of estrogen signaling in ASM, which could contribute to increased airway contractility in women exposed to CS
Introduction
Exposure to cigarette smoke (CS) increases the incidence of airway diseases such as asthma and bronchitis. Lower airway mucosal inflammation and bronchial hyperreactivity occur commonly not only in smokers, but also following secondhand smoke (SHS) exposure [1, 2] . Here, lungs of adolescent girls may be more vulnerable to the effects of smoking [3] . Studies also suggest that 30% of women smoke during their reproductive years in the United States and others are highly susceptible to SHS [4] . Interestingly, unlike men who tend to show emphysematous changes in their lungs, women experience more asthmatic symptoms with CS, suggesting effects on the conducting airways [5] . However, the underlying mechanisms are not known.
There is increasing recognition that lung function is modulated by sex steroids, particularly estrogens [6] [7] [8] [9] [10] , and that sex steroids may play a role in diseases such as asthma, COPD and pulmonary fibrosis. Accordingly, a relevant question is whether and how CS interacts with estrogen signaling in airways of females to affect airway contractility. Estrogen effects are mostly mediated via ERα or ERβ, and both receptors are present in the ASM [11] . Estrogen regulates multiple cellular functions in a variety of cell types in the lung. Here we are focusing on airway smooth muscle (ASM) cells, given their role in contractility, and evidence that this cell type is frequently affected by CS exposure [12] [13] [14] . While the mechanisms by which sex steroid action in the airway are still under exploration [6] [7] [8] 10] , there is now evidence that as in the vasculature, estrogens can induce bronchodilation, by reducing intracellular Ca 2+ ([Ca 2+ ] i ) in ASM [6, 7] . Accordingly, we explored the hypothesis that CS detrimentally influences estrogen signaling in ASM.
ASM contractility and relaxation determines airway tone by maintaining bronchoconstriction and bronchodilation. [Ca 2+ ] i responses to bronchoconstrictor agonist involve sarcoplasmic reticulum (SR) Ca 2+ release as well as Ca 2+ influx [15] [16] [17] , with the latter occurring via voltage-gated or receptor-operated channels, or due to SOCE following SR Ca 2+ depletion [18] [19] [20] [21] . Our previous studies demonstrated that in human ASM, functional estrogen receptors (ERs) exist and that estrogens acutely (i.e. non-genomically) reduce agonistinduced [Ca 2+ ] i levels [6] , by potentially enhancing cAMP signaling [7] . We hypothesize that dysregulation of estrogen signaling by CS results in the loss of an important bronchodilatory component, contributing to smoking-related diseases. To test this hypothesis, we have used human ASM cells to address: 1) Potential cigarette smoke effects on altered estrogen [Ca 2+ ] i regulation, which plays an important role in airway tone; and 2) CS extract (CSE) effect of specific ER expression and function.
Materials and Methods
Materials DMEM/F-12, fetal bovine serum, Hanks Balanced Salt Solution (HBSS), and Fura-2 AM were purchased from Life Technologies (Carlsbad, CA); ERα(ab2746 1:1000 dilution) stromal interaction molecule 1 (STIM1; ab62031, 1:1000 dilution), Phosphoserine (ab17465, 1:1000 dilution), S-nitrosocysteine (ab50185, 1:1000 dilution) and TMEM66 (ab154538, 1:1000 dilution) primary antibodies from Abcam (Cambridge, MA); ERβ(MA1-81281, 1:500 dilution)antibody from ThermoFisher Scientific (Waltham, MA); calcium releaseactivated calcium modulator 1 (Orai1; ACC-060, 1:1000 dilution) primary antibody from Alomone labs (Israel); Protein A/G plus agarose were from Santa Cruz Biotechnology (Santa Cruz, CA). (R,R)-5, 11-diethyl-5,6,11,12-tetrahydro-2,8-chrysenediol [(R,R)-THC] and diarylpropionitrile (DPN) were from Tocris Biosciences (Ellisville, MO). All other reagents and chemicals were purchased from Sigma (St. Louis, MO) unless otherwise specified.
Isolation of Human ASM Cells
Under a Mayo IRB-approved protocol, human bronchi (3rd generation or higher) were obtained from lung resection samples incidental to patient thoracic surgery at Mayo Clinic for focal tumors (bronchoalveolar Sathish et 
carcinoma and infections were excluded) only samples from normal areas of the lung (identified by the pathologist) were utilized. While patient identifiers are not retained with the samples, medical histories are used to select samples from female non-smokers without other significant chronic airway disease such as asthma. ASM cells were isolated and cultured using previously established procedures [13, [22] [23] [24] [25] . Briefly, smooth muscle from lung tissues was dissected after the epithelium was removed by mild abrasions. The tissue was minced in ice cold Hanks' balanced salt solution (HBSS) containing 2 mM Ca 2+ and ASM cells isolated using papain/collagenase digestion, separated by ovomucoid/albumin gradient centrifugation, and resuspended in DMEM/F12 medium with 10% fetal bovine serum (FBS). Cells were plated and maintained in 10% FBS DMEM/F12 media at 37°C (5% CO 2 , 95% air) until 80% confluent and then serum deprived in DMEM/F-12 for 48h, to enter cells into a quiescent stage (maintaining contractile phenotype and receptor expression). Experiments were performed in cells less than 3 rd passage. To verify phenotype stability, the presence of multiple smooth muscle markers such as α-actin, myosin, calponin and caldesmon were confirmed periodically.
CSE Preparation
CSE solution was prepared by modified method of Blue and Janoff [26] and freshly prepared for each experiment with reference cigarettes of standardized composition (U of Kentucky). Briefly, cigarette smoke (1 cigarette to 1 cm butt length/10 ml medium) was drawn into a 60 ml syringe and then slowly bubbled through the medium. Following CSE preparation, pH corrected (7.4), then the solution was filtered (0.2 µm) and used for cell treatment [13, 27] .
] i imaging of human ASM has been previously described [13, [23] [24] [25] . In 8-well borosilicate coverglass chambers, human ASM cells were incubated with 5 µM fura-2/AM for 45 min at room temperature, washed, mounted on the microscope stage and perfused with HBSS. Cells (15-30/field) were imaged in real time using a Nikon Eclipse TE2000-U fluorescent microscope and imaging system software (MetaFluor; Universal Imaging, Downingtown, PA). Baseline [Ca 2+ ] i and responses to agonist were recorded.
Western Blot Analysis
Standard procedures were followed. Proteins were separated by SDS-PAGE using a Criterion Gel System (4-15% gradient; Bio-Rad, Hercules, CA) and transferred to nitrocellulose membranes. After blocking, appropriate primary and secondary antibodies were applied. Protein bands and relative densities were measured using either chemiluminescence substrate (Pierce Chemical Co., Rockford, IL) or farred fluorescence imaging (Li-Cor Odyssey imaging system). For STIM1 phosphorylation studies, after treatment with cyclopiazonic acid (10 μM, CPA) for 5 min, cells were harvested and lysed using RIPA buffer (ThermoFisher Scientific) supplemented with protease inhibitor cocktail (Roche diagnostics). Cells were further disrupted by sonication for 10 s in ice cold conditions followed by centrifuging at 10,000 xg for 10 min at 4°C. Collected supernatant was then used for standard immunoprecipitation protocol [28] . Briefly, BSA-treated A/G plus agarose was added to 100µg protein of cell lysates and was rotated for 30 min at 4 o C. Centrifugation was used to remove nonspecific proteins bound to the A/G plus agarose; the remaining supernatant was used for immunoprecipitation. Supernatant sample was combined with anti-STIM1 (1 µg) and 50µL A/G agarose complex, and rotated overnight at 4 o C. Following incubation, lysate-complexes were pelleted using centrifugation and washed four times with cold washing buffer (20mM HEPES 7.4 pH, 150 nM NaCl, 1mM EDTA, 0.5% Tween20). Pellets were resuspended in 50µL of sample buffer and proteins were separated using standard SDS-Page. Proteins were transferred to a nitrocellulose membrane, and immunoblotted with primary anti-phospho-serine antibody. In parallel, 25µg of cell lysate from the same sample was subjected to SDS-PAGE and immunoblotted for input protein controls [29] .
cAMP ELISA Human ASM cells were grown to confluence in 100 mm plates, treated with CSE for 24 h and then washed with HBSS. Cells were then exposed to agonist in the presence of 0.5 mM IBMX for 15 min. After treatment, cells were scraped and lysed in the presence of protease inhibitor cocktail (Roche Life sciences). cAMP levels in whole cell lysate were determined by competitive-binding enzyme immunoassay (Cell Bio
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Labs, San Diego, CA,) per manufacturer's protocol. Absorbance was measured using a Molecular Devices Flexstation 3 (Sunnyvale, CA).
Immunodetection of S-Nitrosocysteine
Human ASM cells were exposed to CSE for 24 h, washed with HBSS and harvested using cell lysis buffer in the presence of protease inhibitors. Equal amount of total protein (100 µg) from each sample was immunoprecipitated overnight by using anti-ERα antibody (1 µg) and A/G agarose (50 µL). Following immunoprecipitation (as described above), samples were resolved by SDS-PAGE and immunodetected using an anti-S-nitrosocysteine antibody by standard protocols. Input control was performed using the same cell lysate for protein normalization.
Force studies
Bronchial rings (4 th -6 th generation) isolated from human lung were epithelium denuded by gentle abration and used for force contractile studies as described previously [13, 25] . Briefly, experiments were conducted in physiological salt solution (PSS) bubbled with 95% O 2 and 5% CO 2 (37 °C). Bronchial rings were then stretched to optimal length using 1 µM acetylcholine (ACh). At this length, samples were incubated with 2% CSE for 24 h. Time control samples were exposed to vehicle only for the same period. Rings were contracted again with 1 µM ACh in the presence or absence of E 2 (20 min incubation prior to contraction). Data were obtained using a custom-built software program (LabView, National Instruments, 1Hz).
Statistical analysis
Bronchial samples from 5 different female patients were used to obtain ASM cells. Each protocol was repeated at least 2 times, although not all protocols were performed in the same samples. Results were compared using one way ANOVA with Student-Newman-Keuls or Dunnet's post hoc analysis. N represents the number of patient samples. Statistical significance was established at p<0.05. All values are expressed as mean ±SE. 2+ ] i responses to estrogen In fura-2 loaded human ASM cells, 24h exposure to 1% or 2% CSE significantly increased peak and plateau [Ca 2+ ] i responses to 10µM histamine, in comparison to vehicle not treated with CSE: effects comparable to our previous reports [13, 27] . In a separate set of cells, acute exposure (20 min) to physiologically-relevant concentration of 1 nM E 2 significantly decreased [Ca 2+ ] i responses to histamine. We had previously shown that such effects lead to bronchodilation [6, 7] . In 1% or 2% CSE-exposed ASM cells, the reducing effect of E 2 on [Ca 2+ ] i was blunted relative to non-CSE vehicle (Fig. 1) .
Results

CSE effects on [Ca
CSE increases estrogen receptor expression
We had previously found that estrogen effects on [Ca 2+ ] i were dependent on estrogen receptors (ERα and ERβ) [6, 7] . In the samples of the present study, we confirmed that human ASM expressed both ERα and ERβ (Fig. 2) . Based on the results obtained in Figure 1 (blunted E 2 mediated [Ca 2+ ] i responses), we expected CSE to reduce ER expression. However, exposure to CSE (1% or 2%, 24h) significantly increased ERα and E Rβ expression (Fig. 2) , raising the question of whether CSE induced ER dysfunction. 2+ ] i responses to ER isoform-specific agonists Since expression of both ERs increased with 24h CSE, we next investigated which receptor was functionally involved in CSE vs. acute effects on [Ca 2+ ] i regulation. We used specific agonists for ERα (THC), ERβ (DPN) and followed the procedure as in Figure 1 , where instead of E 2 , THC or DPN (10 nM) were used. Acute effects on [Ca 2+ ] i were mediated largely by a ERα agonist but not by a ERβ agonist (Fig. 3) . With 24h CSE exposure, the acute effect of THC on reducing [Ca 2+ ] i responses to histamine was absent (Fig. 3) . influx [30] [31] [32] [33] [34] . We have previously shown that store-operated Ca 2+ entry is a major influx mechanism in ASM [19, 35, 36] and that estrogens can blunt SOCE in human ASM cells [6] . The effects of CSE per se on SOCE or their regulatory mechanisms are largely unknown. Exposure to CSE (24h) significantly increased SOCE responses in comparison to vehicle. E 2 significantly decreased SOCE-mediated Ca 2+ influx compared to vehicle (Fig. 4) . However, 24h CSE exposure blunted the inhibitory Ca 2+ influx effect of E 2 on SOCE (Fig. 4) . 
CSE increases [Ca
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Western blot analysis of lysates from human ASM cells exposed 24 h to 1% or 2% CSE showed a significant increase in the SOCE regulatory proteins STIM1 and Orai1 compared to vehicle (Fig. 5) . Additionally, we found expression of the newly-identified protein SARAF (SOCE-associated regulatory factor previously known as TMEM66), a negative regulator of STIM1/SOCE [37, 38] . With CSE exposure, SARAF expression remained unchanged, while the SARAF/STIM1 ratio was substantially reduced (Fig. 5B, D) which may explain the significantly increased SOCE following CSE exposure (Fig. 4) . In a subset of studies, freshly isolated human ASM tissues were exposed 24 h to 1% or 2% CSE. Similar to isolated human 
ASM cells, ASM tissues also showed significant increase in the expression of STIM1 and Orai1 (Fig. 5 C) , confirming that the biochemical results were not an artifact of cell isolation and/ or culture. Recent studies by Sheridan et al. [39] showed that estrogen acutely (non-genomic) inhibits phosphorylation and aggregation of STIM1, and thus reduces SOCE in bronchial epithelial cells. To explore whether similar mechanisms are present in human ASM, cells were incubated with CSE (24h) alone or in the presence of E 2 (15 min acute exposure prior to addition of CPA), followed by treatment with CPA (10 µM) for 5 min. Cells were subjected to immunoprecipitation for STIM1, and then probed for phospho-serine (primary antibody recognizing proteins phosphorylated on multiple serine residues). Small aliquots of the cell lysate were used as an input control for total STIM1 and normalized with phospho-serine STIM1. E 2 exposure significantly reduced serine phosphorylation of STIM1. CSE exposure significantly increased the CPA activated STIM1 phosphorylation and prevented E 2 -mediated inhibitory effects on phosphorylation of STIM1 (Fig. 6) .
We recently reported that estrogen acutely increases cAMP in human ASM cells thereby reducing [Ca 2+ ] i [7] . To determine whether the blocking effect of CSE in human ASM cells occurs through interference with this mechanism, cAMP was measured using competitivebinding ELISA. CSE exposure (24 h) significantly decreased intracellular cAMP compared to vehicle. Acute exposure to E 2 (15 min) significantly increased cAMP in human ASM cells (Fig.   Fig. 5 . In CSE-exposed cells the effect of E 2 on cAMP levels was significantly blunted, indicating the loss of an important mechanism for reducing [Ca 2+ ] i by estrogen with CSE exposure.
CSE increases S-nitrosylation of ERα
To decipher the mechanistic differences observed in the expression and function of ERα following CSE exposure, ERα nitrosylation was measured based on the idea that several components in CS have nitrosylating effects. A previous study by Garban et al. [40] demonstrated S-nitrosothiol modification of a cysteine residue within ERs resulting in a significant reduction of function. To measure nitrosothiol modification of ERα in ASM cells, ERα was immunoprecipitated and immunoblotted against S-nitrosocysteine. CSE (1% or 2%, 24h) exposure significantly increased S-nitrosocysteine following protein normalization to ERα (Fig. 8) , indicating increased nitrosothiol formation within ERα.
CSE blunts estrogen-induced reduction in ASM contractility
Epithelium-denuded human bronchial rings stretched to optimal length produced the typical, sustained force responses to 1 µM ACh. Acute exposure (20 min) to 10 nM E 2 significantly reduced force production in control conditions (Fig. 9) . 24 h exposure to CSE significantly increased force responses to ACh, compared to vehicle which was consistent with our previous contractility studies [13, 14, 41] . Acute exposure of E 2 did not reduce force responses to ACh for CSE-exposed rings (Fig. 9) . 6 . CSE alters STIM1 phosphorylation. Immunoprecipitation for phospho serine-STIM1 following activation of SOCE by CPA (10µM) was used as an index of STIM1 activation. Acute exposure to E 2 significantly inhibited STIM1 phosphorylation while 2% CSE significantly enhanced STIM1 phosphorylation. The E 2 effect on inhibition of STIM1 phosphorylation was absent in 24h CSE-exposed human ASM cells, consistent with effects on SOCE in ASM cells. Aliquots of the cell lysates from the samples were used to detect input STIM1 and served as a loading control. Values represented as means ± SE (n=4).
# indicates significant E 2 effect compared to vehicle, *indicates significant CSE effect compared to vehicle and/or E 2 group (P < 0.05).
Fig. 7.
Role of estrogen on cAMP levels. In human ASM cells, 24 h exposures to CSE significantly decreased intracellular cAMP compared to vehicle. Acute exposure to E 2 (20 min) significantly increased intracellular cAMP in human ASM cells compared to vehicle. CSE exposure significantly reduced the effects of E 2 on intracellular cAMP production. Values represented as means ± SE (n=4). *indicates significant CSE effect compared to vehicle, # indicates significant E 2 effect compared to vehicle, Fig. 8 . CSE increases S-nitrosylation of ERα Human ASM cells exposed for 24 h to CSE (1% and 2%) were immunoprecipitated for ERα and immunoblotted against anti-S-nitrosocysteine antibody. Aliquots of the cell lysates from the samples were used to detect input ERα and served as a loading control. CSE-exposed ASM cells significantly increased ERα nitrosylation compared to vehicle. Values represented as means ± SE (n=4). *indicates significant CSE effect compared to vehicle (P < 0.05). Fig. 9 . Effect of CSE and estrogen on human ASM force responses. Epithelium-denuded bronchial rings demonstrated stable force responses to 1 μM ACh. 24h exposure to 2% CSE significantly enhanced force responses, compared to pre-exposure values, as well as time controls. Acute exposure to E 2 (20 min) significantly reduced force responses to ACh, but this E 2 effect was absent in CSE-exposed bronchial rings. Values represented as means ± SE (n=4) # indicates significant E 2 effect compared to vehicle, *indicates significant CSE effect compared to vehicle and/or E 2 group (P < 0.05). Sathish 
airways may be more affected in women with greater incidence of asthma and bronchitis, compared to more COPD in men [48, 50, 51] . On the other hand, several studies including our own have shown that estrogens can be bronchodilatory, and thus offer a "protective" role. Therefore, the question arises as to whether such beneficial effects of estrogens are maintained in the presence of CS exposure. We focused on a major structural and functional element of the airway, i.e. ASM, which regulates airway tone, and the effect of CS on estrogeninduced changes in [Ca 2+ ] i . To our knowledge, this is the first study to establish the influence of CS on acute estrogen effects on [Ca 2+ ] i.
Estrogen signaling in the airway
Estrogen effects can be mediated by two receptors, ERα and ERβ [6, 9] , acting via classical, genomic mechanisms of altered protein expression/function, or in acute, nongenomic fashion. The vasodilatory effects of estrogens are well-known. Acute exposure to clinically-relevant E 2 concentrations (<10 nM) blunts agonist-induced [Ca 2+ ] i responses [30, 31] . In coronary artery, [32] carotid artery [33] and aorta [34] [31, 52] . In human platelets, the synthetic estrogen agonist diethylstilbestrol inhibits SOCE [53] . One study in mouse airways sensitized by serum from asthmatic humans demonstrated acute bronchodilation by E 2 [10] . Novel data from our group indicate that clinically-relevant concentrations of estrogen normally produce bronchodilation in human airways, by reducing ASM [Ca 2+ ] i [6] enhancing NO release by airway epithelium [8] and potentially improving beta-adrenergic signaling [7] .
Cigarette Smoke Exposure in the Airway
Cigarette smoking can exacerbate respiratory disorders such as asthma and bronchitis, which are characterized by airway inflammation and exaggerated airway narrowing (hyperreactivity). There is currently limited but increasing information on this aspect of CSrelated airway disease, ranging from smoke challenge studies in humans and animal models [54] [55] [56] to cellular mechanisms involving ASM [13, 14, 41] . However, there is currently little information on sex differences in CS-induced changes in the airway, particularly mechanisms by which CS alters estrogen signaling in ASM. This has important clinical relevance due to increasing rates of female smokers (and exposure to SHS from spouses) and greater numbers of women now diagnosed with chronic obstructive pulmonary disease (COPD) [42, 43] , highlighting the importance of the current study.
[ [22, 59] and mitochondrial Ca 2+ buffering [60, 61] . Only a few studies including our own [6, 8, 62] have examined ER expression within the airway, especially in humans, and have reported expression of the classical estrogen receptors (ERα and ERβ). Additionally, we have previously shown that acute exposure to physiological concentrations of E 2 decreases [Ca 2+ ] i response to histamine, an effect reversed by the ER antagonist ICI-182,780 [6] . The inhibition of Ca 2+ influx works through several mechanisms, one of which we previously published by inhibiting voltage gated Ca 2+ channels through activation of the PKA /cyclic AMP pathway [6] . Here, we provide evidence that inhibition of SOCE [6] by estrogen occurs through alteration in STIM1 phosphorylation.
The present study also demonstrates that CSE reduces intracellular cAMP production which may allow for increased effects of CSE on agonist-induced [Ca prenatal lung showed that CS decreases cAMP levels and leads to airway hyperresponsiveness [63] . The cAMP/PKA pathway regulates multiple Ca 2+ regulatory mechanisms in human ASM. Our novel data suggest that estrogen-mediated production of cAMP is reduced by CSE exposure leading to increased [Ca 2+ ] i in ASM cells. We also found that CSE exposure substantially enhances expression of both ERs. These interesting data highlight the fact that even with increased ER expression; ER-mediated signaling is significantly blunted with CSE exposure, leading to dysfunctional ER signaling in the airway, as also reflected by impaired downstream cAMP production in human ASM. In this regard, CS may also alter adenylate cyclase expression and activity, an aspect beyond the scope of our study, but a potentially important point for future investigation.
Previous studies suggest that Orai1 and STIM1 (calcium channel and calcium sensor respectively) are key mediators of SOCE [64] . Both Orai1 and STIM1 proteins are molecular constituents of capacitative calcium entry which is activated upon depletion of intracellular Ca 2+ stores. Previously, we [35, 36] and others [57, 65, 66] have shown that in vitro exposure to pro-inflammatory cytokines TNFα, and IL-13 can increase SOCE response and expression of major SOCE regulatory proteins STIM1 and Orai1 in human ASM. The present study is the first to demonstrate increased expression of STIM1 and Orai1 with CSE exposure. To avoid confounding results due to ASM culture vs. freshly isolated tissues in the expression of STIM1 and Orai1 [67] , we confirmed SOCE regulatory protein expression using freshly dissected ASM tissue as well. Additionally, we report the constitutive expression of newly identified protein SARAF [37, 38] , a negative regulator of SOCE in human ASM cells. Notably, CSE exposure did not change the expression of SARAF, suggesting that inhibition of SOCE may not necessarily be influenced. However due to the increase in STIM1 expression, the ratio of SARAF to STIM1 was significantly reduced. This change in ratio may suggest a propensity for maintained SOCE with CSE exposure, as found in our study. Furthermore, reduced SARAF ratio to STIM1 can lead to increased STIM1 aggregation, as shown in other cell types [37, 38] resulting in significantly enhanced SOCE with cigarette smoke exposure.
After ER/SR Ca 2+ depletion, STIM1 transforms from a dimer and oligomerizes leading to SOCE activation [68] . Sheridan et al. recently showed that acute exposure to E 2 inhibits STIM1 mobility in airway epithelial cells by inhibiting serine phosphorylation of STIM1, thereby reducing SOCE [39] . A consistent finding in our study was is that CSE significantly increased CPA-induced serine phosphorylation of STIM1 in ASM. Thus the inhibitory effect of estrogen on phosphorylation of STIM1 is blunted by CSE, permitting increased SOCE. These data collectively show multiple targets for cigarette smoke-induced SOCE activation and increased [Ca 2+ ] i signaling in human ASM.
Cigarette Smoke Effects on Estrogen Receptors
Consistent with the idea that on one hand estrogens decrease [Ca 2+ ] i in ASM, while CSE enhances [Ca 2+ ] i , we expected CSE to reduce ER expression. However, CSE appears to increase especially ERα suggesting that CS exposure results in ER dysfunction. While there may be a myriad of potential mechanisms by which such dysfunction occurs, our observation of increased S-nitrosothiol formation on ERα may be one such pathway, especially given our finding that the observed increase in S-nitrosylation of ERα was disproportionately greater than changes in receptor expression with CSE exposure. The alteration of protein function by S-nitrosylation indicates that nitrosothiols might function as a significant post-translational modification similar to phosphorylation or acetylation [69, 70] . There has been supporting evidence that possible modification of thiol-containing residues can lead to modulation of ERα function [40] . Furthermore the observed modifications with CSE exposure to ERα may partially involve a decrease in Ca 2+ regulatory mechanisms via estrogen. These functional cellular studies were further confirmed by force studies on human bronchial rings where CSE exposure completely blunted the ability of estrogen to acutely reduce force generation.
In summary, clinically-relevant estrogen concentrations significantly decrease [Ca 2+ ] i in ASM, thereby facilitating bronchodilation in human ASM. In contrast, CS which enhances [Ca
